Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

被引:447
|
作者
Kumashiro, Naoki [1 ,2 ]
Erion, Derek M. [1 ,2 ,3 ]
Zhang, Dongyan [2 ]
Kahn, Mario [1 ]
Beddow, Sara A. [1 ]
Chu, Xin [4 ]
Still, Christopher D. [4 ]
Gerhard, Glenn S. [4 ]
Han, Xianlin [5 ]
Dziura, James [1 ]
Petersen, Kitt Falk [1 ]
Samuel, Varman T. [1 ,6 ]
Shulman, Gerald I. [1 ,2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA
[4] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA
[5] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA
[6] Vet Affairs Med Ctr, West Haven, CT 06516 USA
关键词
PROTEIN-KINASE-C; ENDOPLASMIC-RETICULUM STRESS; HEPATIC STEATOSIS; METABOLIC SYNDROME; CERAMIDE SYNTHESIS; SKELETAL-MUSCLE; OBESE SUBJECTS; TISSUE; TRIGLYCERIDE; ACTIVATION;
D O I
10.1073/pnas.1113359108
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Insulin resistance is associated with nonalcoholic fatty liver disease (NAFLD) and is a major factor in the pathogenesis of type 2 diabetes. The development of hepatic insulin resistance has been ascribed to multiple causes, including inflammation, endoplasmic reticulum (ER) stress, and accumulation of hepatocellular lipids in animal models of NAFLD. However, it is unknown whether these same cellular mechanisms link insulin resistance to hepatic steatosis in humans. To examine the cellular mechanisms that link hepatic steatosis to insulin resistance, we comprehensively assessed each of these pathways by using flash-frozen liver biopsies obtained from 37 obese, nondiabetic individuals and correlating key hepatic and plasma markers of inflammation, ER stress, and lipids with the homeostatic model assessment of insulin resistance index. We found that hepatic diacylglycerol (DAG) content in cytoplasmic lipid droplets was the best predictor of insulin resistance (R = 0.80, P < 0.001), and it was responsible for 64% of the variability in insulin sensitivity. Hepatic DAG content was also strongly correlated with activation of hepatic PKCe (R = 0.67, P < 0.001), which impairs insulin signaling. In contrast, there was no significant association between insulin resistance and other putative lipid metabolites or plasma or hepatic markers of inflammation. ER stress markers were only partly correlated with insulin resistance. In conclusion, these data show that hepatic DAG content in lipid droplets is the best predictor of insulin resistance in humans, and they support the hypothesis that NAFLD-associated hepatic insulin resistance is caused by an increase in hepatic DAG content, which results in activation of PKCe.
引用
收藏
页码:16381 / 16385
页数:5
相关论文
共 50 条
  • [21] Apoptosis and Disease Severity is Associated with Insulin Resistance in Nonalcoholic Fatty Liver Disease
    Atay, Kadri
    Canbakan, Billur
    Koroglu, Emine
    Hatemi, Ibrahim
    Canbakan, Mustafa
    Kepil, Nuray
    Tuncer, Murat
    Senturk, Hakan
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2017, 80 (02): : 271 - 277
  • [22] Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: is it different?
    Panigrahi, Manaskumar
    Singh, Shivaramprasad
    Misra, Bijay
    Singh, Ayaskanta
    Kar, Sanjibkumar
    Misra, Debasis
    Pati, Girishkumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 632 - 633
  • [23] Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
    Akhtar, Daud H.
    Iqbal, Umair
    Vazquez-Montesino, Luis Miguel
    Dennis, Brittany B.
    Ahmed, Aijaz
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (04) : 362 - 370
  • [24] Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
    Conlon, Beth A.
    Beasley, Jeannette M.
    Aebersold, Karin
    Jhangiani, Sunil S.
    Wylie-Rosett, Judith
    NUTRIENTS, 2013, 5 (10) : 4093 - 4114
  • [25] Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
    Polyzos, Stergios A.
    Kountouras, Jannis
    Zavos, Christos
    CURRENT MOLECULAR MEDICINE, 2009, 9 (03) : 299 - 314
  • [26] Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
    Maha Assem Hussein
    May Fawzi
    Alhosaeyn Ibrahim
    Aasem Saif
    The Egyptian Journal of Internal Medicine, 2018, 30 (3) : 97 - 102
  • [27] Nonalcoholic fatty liver disease, insulin resistance, and sweeteners: a literature review
    Kakleas, Konstantinos
    Christodouli, Foteini
    Karavanaki, Kyriaki
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2020, 15 (02) : 83 - 93
  • [28] Dietary and lifestyle indices for insulin resistance and nonalcoholic fatty liver disease
    Momeni, Aref
    Jahromi, Soodeh Razeghi
    KazemiJahromi, Mitra
    Teymoori, Farshad
    Farhadnejad, Hossein
    Haghshenas, Rouhollah
    NUTRITION & FOOD SCIENCE, 2024, 54 (01): : 45 - 55
  • [29] The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease
    Orlik, Bartlomiej
    Handzlik, Gabriela
    Olszanecka-Glinianowicz, Magdalena
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2010, 64 : 212 - 219
  • [30] Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?
    Singh, Shivaram Prasad
    Misra, Bijay
    Kar, Sanjib Kumar
    Panigrahi, Manas Kumar
    Misra, Debasis
    Bhuyan, Pallavi
    Pattnaik, Kaumudee
    Meher, Chudamani
    Agrawal, Omprakash
    Rout, Niranjan
    Swain, Manorama
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (04) : 482 - 488